No Data
Express News | Biotron: Core technical staff member Wang Xinfeng resigns.
Net income sharply declined with the contraction of overseas sales, Botai Biology opens up the microfluidic testing field | Earnings conference
①The rapid decline in overseas income dragged down the performance of Botuo Life Sciences, with overall revenue significantly decreasing compared to before the epidemic, and net income attributable to shareholders has decreased year-on-year for multiple years; ② Considering changes in the external environment, Botuo Life Sciences has terminated two major core investment projects, added the Microfluidic Fluorescence Detection Platform project, and ventured into the microfluidic technology field.
Botuo Biotech Report for the Third Quarter of 2024
Express News | Next week, the restricted shares will be unlocked, increasing the market cap to 54.9 billion yuan, which is at a moderate level among annual weekly data.
Summary of Botuo Biotech\'s 2024 Semi-Annual Report
Botuo Biotech 2024 Semi-Annual Report
No Data